🇺🇸 FDA
Patent

US 10457662

Substituted amides for treating and preventing cancer

granted A61KA61K31/4706A61K31/4709

Quick answer

US patent 10457662 (Substituted amides for treating and preventing cancer) held by The Board of Regents of the University of Texas System expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4706, A61K31/4709, A61K31/497, A61K31/498